All Resources

At the BR1DGE symposium at IDS 2024, leading experts shared new insights on the mechanisms driving autoimmune type 1 diabetes (T1D), emphasizing the benefits of genetic risk scoring, and the latest biomarker research.  

This article is intended to be a summary only. Additional topics were covered in the live symposium in line with the applicable regulations but are not included on the BR1DGE platform. 

At the BR1DGE symposium at ISPAD 2024, leading experts shared their insights on the importance of screening for islet autoantibodies (IAb) to identify early-stage (Stage 1 and 2) autoimmune type 1 diabetes (T1D). Early identification, followed by monitoring and education, is crucial to help prepare people for a life with T1D.

This article is intended to be a summary only. Additional topics were covered in the live symposium in line with the applicable regulations but are not included on the BR1DGE platform. 

At the BR1DGE symposium at EASD 2024, leading experts shared new insights on early-stage (Stage 1 and 2) autoimmune type 1 diabetes (T1D), emphasizing the importance of screening for islet antibodies (IAbs) together with monitoring and education. Early type 1 diabetes identification can help to prepare people for a life with T1D.

This article is intended to be a summary only. Additional topics were covered in the live symposium in line with the applicable regulations but are not included on the BR1DGE platform.

An infographic exploring how to differentiate T1D from T2D, which is essential to prevent misdiagnosis and associated complications.  

Explore the stages of type 1 diabetes

Learn about the psychosocial impacts of type 1 diabetes and explore expert guidance on how to integrate psychosocial care into routine care.

This animated video provides an overview of the key immunological processes that underlie the development of autoimmunity in T1D. Autoreactive T cells drive pancreatic beta-cell destruction, resulting in insulin deficiency and, ultimately, hyperglycemia and symptoms of T1D.

Professor Emanuele Bosi discusses a mandatory screening program for Type 1 diabetes and celiac disease in children and adolescents, launched in Italy in 2024.

An overview of the screening methods for autoimmune type 1 diabetes (T1D).

Staging of autoimmune T1D allows us to track the progressive nature of the disease, from autoimmunity through to insulin dependence. 

Expert consensus on monitoring individuals with T1D islet autoantibodies: detection, monitoring frequency, and psychosocial support for managing autoimmune T1D.

Screening for autoimmune T1D involves testing for autoantibodies that are markers of destruction of insulin-producing beta cells.